Publication | Closed Access

Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial

VaccinationClinical MalariaBurkina FasoMalariaImmunologyVaccine TrialVaccine EfficacyImmunotherapyMedicineVaccine ResearchR21/matrix-m Vaccine